Session Invited Program IM/TH- Radiopharmaceutical Therapy

Targeted radiation from within: the expanding role of radiopharmaceutical therapy

Description

As precision oncology evolves, the goal is for RPT to be viewed as a bridge between nuclear medicine, radiation oncology and medical oncology for the benefit of patients with cancer. However, challenges remain related to items, such as “turf wars” between departments wishing to “own” the treatment, technical factors related to coupling of RPT with external beam radiation (composite doses) needed for overall dosing and dose-volume-effect relationships, and training future medical physicists, etc. There is also a shortage of authorized users (AU’s) and authorized medical physicists (AMP’s) needed to manage the quickly evolving workloads. It behooves the AAPM to tackle these issues through education and collaborative approaches to achieve the most effective integrated care for the benefit of patients with cancer. Addressing these issues also highlights the importance of preparing medical physics trainees with the skills and knowledge necessary to meet evolving clinical demands. While accreditation and professional bodies such as CAMPEP and the AAPM continue to develop guidelines for training programs, this session aims to share perspectives and challenges from institutions that have already incorporated RPT training into their curricula. It will also provide practical strategies to strengthen RPT education and foster collaboration across programs, ultimately supporting the development of a well-prepared workforce.

People

Related

Similar sessions

Session Invited Program Room 205
Jul 19 · 13:15
Dosimetry in Radiopharmaceutical Therapy: Why it matters

This educational session will address why dosimetry is central to modern radiopharmaceutical therapy. It will highlight how fixed-activity approaches emerged historically and why they are increasingly insufficient in the context...

Robin Peter, PhD Alejandro Bertolet, PhD Alejandro Bertolet, PhD
IM/TH- Radiopharmaceutical Therapy 0 people interested
Session Invited Program Room 205
Jul 19 · 14:25
Dosimetry in Radiopharmaceutical Therapy: How to Do It

This session will present a structured, educational overview of how to perform patient-specific dosimetry in radiopharmaceutical therapy, using AAPM TG-381 as a reference framework. The first part will walk through generalizable...

Alejandro Bertolet, PhD David P. Adam, PhD, MS
IM/TH- Radiopharmaceutical Therapy 0 people interested
Session Invited Program Room 205
Jul 20 · 08:40
Basic Y-90 Image-Based Dosimetry Workshop: Past and Present

Interactive, educational, hands-on session (60 min total). The first part focuses on participant interaction with the web demo; the second part provides an expert synthesis of results. Emphasis is on building intuition rather tha...

Nichole Millward Maughan, PhD Alejandro Bertolet, PhD
IM/TH- Radiopharmaceutical Therapy 0 people interested
Session Invited Program Room 205
Jul 20 · 13:15
A Primer on Radiopharmaceutical Therapy Radiobiology

Radiopharmaceutical therapy (RPT) is re-shaping how radiation is used to combat cancer since it provides a way to deliver radiation systemically. Due to its impactful clinical applications, RPT has been approved by the FDA to tre...

Alejandro Bertolet, PhD Robin Peter, PhD Gabriel O. Sawakuchi, PhD
IM/TH- Radiopharmaceutical Therapy 0 people interested
Session Invited Program Room 205
Jul 20 · 16:00
Personalized Dosimetry in Clinical Trials for Beta-Emitting Radiopharmaceutical Dosimetry

Personalized dosimetry in radiopharmaceutical therapy (RPT) is gaining strong interest because fixed-activity regimens often fail to capture the large variability in how patients respond to the treatment. Growing evidence shows c...

Robert Francois Hobbs, PhD Alejandro Bertolet, PhD Carlos Huesa-Berral, PhD
IM/TH- Radiopharmaceutical Therapy 0 people interested
Session Invited Program Room 205
Jul 21 · 08:40
Ask the Experts: A Roundtable Session on Radiopharmaceutical Therapy

At the AAPM 2025 conference, these speakers conducted a 90-minute session titled “Building a Radiopharmaceutical Therapy Program and Expanding to Clinical Trials.” Following the talks and the ten-minute Q&A session, the audience...

Jonathon W. Mueller, MS Susan L. Richardson, PhD Carlos Uribe, PhD
IM/TH- Radiopharmaceutical Therapy 0 people interested